SCHEMBL367664

SCHEMBL367664

CC(=O)c1sc(Nc2nccc(C)n2)nc1-c1cn[nH]c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 4/20 0.72
GRM8 O00222 1/20 0.72
ALDH1A1 P00352 7/20 0.44
HPGD P15428 2/20 0.44
NPC1 O15118 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
RAB9A P51151 4/20 0.42
PKM P14618 1/20 0.42
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPT P10636 1/20 0.41
HIF1A Q16665 1/20 0.41
KMT2A Q03164 3/20 0.38
TSHR P16473 1/20 0.38
RXFP1 Q9HBX9 3/20 0.38
MAPK10 P53779 1/20 0.38
MAPK8 P45983 1/20 0.37
MAP3K5 Q99683 1/20 0.37
MEN1 O00255 1/20 0.37
DHODH Q02127 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL369060 0.84 GRM4 (1.00) GRM4GRM8ALDH1A1NPC1SMN1; SMN2
SCHEMBL370475 0.82 GRM4 (0.79) GRM4GRM8NPC1SMN1; SMN2RAB9A
SCHEMBL2502005 0.80 GRM4 (0.74) GRM4GRM8NPC1SMN1; SMN2RAB9A
SCHEMBL370559 0.80 GRM4 (0.74) GRM4GRM8NPC1SMN1; SMN2RAB9A
SCHEMBL369661 0.74 GRM8 (0.41) GRM4GRM8ALDH1A1SMN1; SMN2PKM
SCHEMBL367343 0.73 GRM4 (0.64) GRM4GRM8ALDH1A1NPC1SMN1; SMN2
SCHEMBL370964 0.73 GRM4 (0.63) GRM4GRM8NPC1SMN1; SMN2RAB9A
SCHEMBL370278 0.72 GRM4 (0.77) GRM4GRM8ALDH1A1NPC1SMN1; SMN2
SCHEMBL370576 0.72 GRM4 (0.76) GRM4GRM8ALDH1A1NPC1SMN1; SMN2
SCHEMBL370889 0.72 GRM4 (0.76) GRM4GRM8ALDH1A1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS BOLEA CHRISTELLE (CH) 2013-08-15 US claimed
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 EP claimed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO claimed
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS BOLEA CHRISTELLE (CH) 2013-08-15 US disclosed
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 EP disclosed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM2, GRM4, GRM1 GRM4 2/4885GRM8 23/4885ALDH1A1 2554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.